Form D · Pharmaceuticals
ARCA biopharma, Inc.
Westminster, CO · CIK 0000907654
Offering snapshot reported Jun 25, 2015 · SEC filing
- Reported sold
- $51.7M Offering amount: $51.7M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 16, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2015 | Initial | $51,650,404 | No comparison | 14 | SEC filing |
| Feb 20, 2014 | Initial | $326,158 | No comparison | 2 | SEC filing |
| Jun 17, 2013 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
| Feb 1, 2013 | Initial | $1,000,000 | No comparison | 5 | SEC filing |
| Dec 28, 2012 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Oct 31, 2012 | Initial | $325,000 | No comparison | 4 | SEC filing |
| Jan 5, 2012 | Initial | $4,549,285 | No comparison | 6 | SEC filing |
| Oct 26, 2009 | Initial | $499,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.59M
- Finders' fees
- $0
- Form D file number
- 021-242529
The Total Offering Amount and Total Amount Sold include the aggregate exercise price of certain warrants to purchase shares of Common Stock of the Issuer.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| MTS Securities, LLC | 104059 |
Source: Form D, filed Jun 25, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard B. Brewer | Director |
| Michael R. Bristow | Director, Executive |
| Robert E. Conway | Director |
| Kathryn E. Falberg | Executive |
| Jean Francois Formela | Director |
| J. William Freytag | Director |
| Linda S. Grais | Director |
| Thomas A. Keuer | Executive |
| Ted W. Love | Director |
| Dan J. Mitchell | Director |
| Christopher D. Ozeroff | Executive |
| Mary K. Pendergast | Director |
| Brian L. Selby | Executive |
| Burton E. Sobel | Director |
| Patrick M. Wheeler | Executive |
| Raymond L. Woosley | Director |
| John L. Zabriskie | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11080 Circlepoint Road Suite 140
Westminster, CO, 80020
Westminster, CO, 80020